Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04766424 · ClinicalTrials.gov registry record · NA

Sleep Technology Intervention to Target Cardiometabolic Health

A NA study of Elevated Blood Pressure and Habitual Sleep Duration of Less Than or Equal to 7 Hours, sponsored by University of Utah.

Active
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT04766424 is a NA study of Elevated Blood Pressure and Habitual Sleep Duration of Less Than or Equal to 7 Hours that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 120 participants, above the 93-participant average among 6 other Elevated Blood Pressure trials with a reported enrollment target (29% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04766424, a NA study of Elevated Blood Pressure and Habitual Sleep Duration of Less Than or Equal to 7 Hours, is active but no longer recruiting, sponsored by University of Utah.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to test the efficacy of a behavioral sleep extension intervention on sleep duration, cardio-metabolic disease risk factors, and health behaviors among adults with elevated blood pressure/hypertension and short sleep duration.

Interventions

  • BEHAVIORAL Health education
  • BEHAVIORAL Sleep extension intervention

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2021-03-30
Est. Completion 2025-06-14
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT04766424

The ClinicalTrials.gov registry entry for NCT04766424 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 93-participant average among 6 other Elevated Blood Pressure trials with a reported enrollment target (29% higher). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Elevated Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Health education is the first listed.

NCT04766424 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT04766424 about?

NCT04766424 is a clinical study titled "Sleep Technology Intervention to Target Cardiometabolic Health". The goal of this study is to test the efficacy of a behavioral sleep extension intervention on sleep duration, cardio-metabolic disease risk factors, and health behaviors among adults with elevated blood pressure/hypertension and short sleep duration.

What is the current status of trial NCT04766424?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2021-03-30. Estimated completion is 2025-06-14.

What conditions does trial NCT04766424 study?

This clinical trial studies the following conditions: Elevated Blood Pressure, Habitual Sleep Duration of Less Than or Equal to 7 Hours.

What interventions are being tested in trial NCT04766424?

The interventions under investigation include: Health education (BEHAVIORAL), Sleep extension intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04766424?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04766424 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Elevated Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.